While clinical research has the power to change lives but often it is not accessible for people who need it most. This led the founder of I & I Research to establish a company that not only conducts clinical trials but also strives to make innovative therapies accessible to populations that dearly need them.
With over a decade’s experience in the healthcare sector, the founder saw firsthand the gap in access to clinical research between Western countries and regions like Asia-Pacific (APAC). While global focus on western markets has led to remarkable results in various therapeutic areas but has produced saturation of clinical research in western markets. Countries with enormous potential, like Pakistan remain underutilized. This imbalance implies that many patients in these localities do not have the opportunity to participate in trials that could provide them with pioneering treatments.
The desire to bridge this gap was the main inspiration that gave birth to I & I Research. The founder envisioned a company that could bring the innovative clinical research to places where it was desperately needed, starting with Pakistan. This vision was not just about expanding market reach; it was about creating opportunities for patients and underutilized investigational sites to be part of global clinical research of investigational therapies; which otherwise are out of their reach.
Pakistan, with its diverse population of over 220 million, offers an ideal environment for clinical research. Its population diversity allows for a broad range of clinical data that can have global relevance. Additionally, the prevalence of both contagious and non- contagious diseases makes it an important location for research that can address significant health challenges.
Recognizing this untapped potential, the founder of I & I Research set out to establish a research service provider that would meet international standards while catering specifically to the needs of the APAC region. The journey was anything but easy. There were numerous challenges, including navigating Pakistan’s complex regulatory environment and overcoming scepticism towards clinical trials. However, the founder’s deep understanding of the pharmaceutical industry and unwavering commitment to the mission enabled I & I Research to overcome these obstacles.
A critical factor in the success of I & I Research has been its ability to build trust with local healthcare community and international clinical researchers. The company engaged extensively with healthcare professionals, explaining the importance of clinical research and how it could benefit both patients and the medical community. This effort has led to strong partnerships with hospitals and clinics across Pakistan, enabling I & I Research to conduct high-quality clinical trials that adhere to global standards.
Moreover, the cost advantages of conducting research in Pakistan cannot be overstated. Lower operational costs, combined with the availability of highly trained healthcare professionals and well-developed medical facilities, make Pakistan an attractive location for sponsors looking to maximize the impact of their research budgets. By establishing a presence in Pakistan, I & I Research has opened new opportunities for global sponsors to conduct trials in a region that offers significant cost savings without compromising on quality.
Today, I & I Research is more than just a service provide; it is a beacon of hope for patients in Pakistan and other underrepresented regions. The company’s work has already led to the introduction of innovative therapies that would otherwise have been inaccessible to these populations. For clinical researchers, the story of I & I Research is an inspiring reminder of why they do what they do. It’s a story of perseverance, vision, and the belief that everyone, regardless of where they live, should have access to the benefits of medical research.
As I & I Research continues to grow, it remains committed to expanding access to life-changing therapies. The company’s future plans include expanding its operations into other APAC countries, always with the same focus on quality, ethics, and patient-centred research. For those involved in clinical research, I & I Research offers not just a job, but a chance to be part of something truly meaningful—bringing the future of medicine to those who need it most.
